{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:48:36Z","timestamp":1786736916337,"version":"build-2736575974"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cardiovasc Echography"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/jcecho.jcecho_4_19","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T08:35:37Z","timestamp":1586507737000},"page":"17","source":"Crossref","is-referenced-by-count":12,"title":["Peripheral artery disease and stroke"],"prefix":"10.4103","volume":"30","author":[{"given":"Concetta","family":"Zito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Manganaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scipione","family":"Carerj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Antonini-Canterin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2211-4122.282280-1","first-page":"2768","volume-title":"2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: The task force for cancer treatments and cardiovascular toxicity of the European society of cardiology (ESC)","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"key-10.4103\/2211-4122.282280-2","first-page":"2242","volume-title":"Bcr-abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia","author":"O'Hare","year":"2007","journal-title":"Blood"},{"key":"key-10.4103\/2211-4122.282280-3","first-page":"663","volume-title":"Monitoring response to tyrosine kinase inhibitor therapy, mutational analysis, and new treatment options in chronic myelogenous leukemia","author":"Radich","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"key-10.4103\/2211-4122.282280-4","first-page":"2542","volume-title":"Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL","author":"Kantarjian","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2211-4122.282280-5","first-page":"2531","volume-title":"Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias","author":"Talpaz","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2211-4122.282280-6","first-page":"533","volume-title":"Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML","author":"Aichberger","year":"2011","journal-title":"Am J Hematol"},{"key":"key-10.4103\/2211-4122.282280-7","first-page":"1316","volume-title":"Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib","author":"Kim","year":"2013","journal-title":"Leukemia"},{"key":"key-10.4103\/2211-4122.282280-8","first-page":"1347","volume-title":"Severe peripheral arterial disease during nilotinib therapy","author":"Le","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/2211-4122.282280-9","first-page":"363","volume-title":"Rapid onset of peripheral artery disease in a chronic myeloid leukemia patient without prior arterial disorder: Direct relationship with nilotinib exposure and clinical outcome","author":"Mirault","year":"2015","journal-title":"Eur J Haematol"},{"key":"key-10.4103\/2211-4122.282280-10","first-page":"47","volume-title":"Risk factors and mechanisms contributing to TKI-induced vascular events in patients with CML","author":"Valent","year":"2017","journal-title":"Leuk Res"},{"key":"key-10.4103\/2211-4122.282280-11","first-page":"1310","volume-title":"Rates of peripheral arterial occlusive disease in patients with chronic myeloid leukemia in the chronic phase treated with imatinib, nilotinib, or non-tyrosine kinase therapy: A retrospective cohort analysis","author":"Giles","year":"2013","journal-title":"Leukemia"},{"key":"key-10.4103\/2211-4122.282280-12","first-page":"901","volume-title":"Vascular safety issues in CML patients treated with BCR\/ABL1 kinase inhibitors","author":"Valent","year":"2015","journal-title":"Blood"},{"key":"key-10.4103\/2211-4122.282280-13","first-page":"2197","volume-title":"Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up","author":"Larson","year":"2012","journal-title":"Leukemia"},{"key":"key-10.4103\/2211-4122.282280-14","first-page":"1593","volume-title":"Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials","author":"le","year":"2016","journal-title":"Leukemia"},{"key":"key-10.4103\/2211-4122.282280-15","first-page":"625","volume-title":"Association between BCR-ABL tyrosine kinase inhibitors for chronic myeloid leukemia and cardiovascular events, major molecular response, and overall survival: A systematic review and meta-analysis","author":"Douxfils","year":"2016","journal-title":"JAMA Oncol"},{"key":"key-10.4103\/2211-4122.282280-16","first-page":"4653","volume-title":"Imatinib mesylate may improve fasting blood glucose in diabetic ph+chronic myelogenous leukemia patients responsive to treatment","author":"Breccia","year":"2004","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/2211-4122.282280-17","first-page":"976","volume-title":"Fatal progressive cerebral ischemia in CML under third-line treatment with ponatinib","author":"Mayer","year":"2014","journal-title":"Leukemia"},{"key":"key-10.4103\/2211-4122.282280-18","first-page":"72311","volume-title":"Genetic predisposition and induced pro-inflammatory\/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients","author":"Bocchia","year":"2016","journal-title":"Oncotarget"},{"key":"key-10.4103\/2211-4122.282280-19","first-page":"337","volume-title":"Nilotinib-associated vascular events","author":"Quint\u00e1s-Cardama","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"key-10.4103\/2211-4122.282280-20","first-page":"1455","volume-title":"Ponatinib reduces viability, migration, and functionality of human endothelial cells","author":"Gover-Proaktor","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"key-10.4103\/2211-4122.282280-21","first-page":"1197","volume-title":"Early onset hypercholesterolemia induced by the 2nd-generation tyrosine kinase inhibitor nilotinib in patients with chronic phase-chronic myeloid leukemia","author":"Rea","year":"2014","journal-title":"Haematologica"},{"key":"key-10.4103\/2211-4122.282280-22","first-page":"2251","volume-title":"Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia","author":"Saglio","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2211-4122.282280-23","first-page":"e124","volume-title":"Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia","author":"Racil","year":"2013","journal-title":"Haematologica"},{"key":"key-10.4103\/2211-4122.282280-24","first-page":"1160","volume-title":"Vascular and metabolic implications of novel targeted cancer therapies: Focus on kinase inhibitors","author":"Li","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/2211-4122.282280-25","first-page":"4210","volume-title":"Tyrosine kinase inhibitor-associated cardiovascular toxicity in chronic myeloid leukemia","author":"Moslehi","year":"2015","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/2211-4122.282280-26","first-page":"617","volume-title":"Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia","author":"Gugliotta","year":"2016","journal-title":"Am J Hematol"},{"key":"key-10.4103\/2211-4122.282280-27","first-page":"23061","volume-title":"TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of ph+CML","author":"Valent","year":"2017","journal-title":"Oncotarget"},{"key":"key-10.4103\/2211-4122.282280-28","first-page":"763","volume-title":"2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European society for vascular surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: The European stroke organization (ESO) the task force for the diagnosis and treatment of peripheral arterial diseases of the European society of cardiology (ESC) and of the European society for vascular surgery (ESVS)","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"key-10.4103\/2211-4122.282280-29","first-page":"793","volume-title":"Stenting versus surgery in patients with carotid stenosis after previous cervical radiation therapy: Systematic review and meta-analysis","author":"Fokkema","year":"2012","journal-title":"Stroke"},{"key":"key-10.4103\/2211-4122.282280-30","first-page":"928","volume-title":"Increased risk of stroke and transient ischemic attack in 5-year survivors of hodgkin lymphoma","author":"De","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/2211-4122.282280-31","first-page":"268","volume-title":"Prospective analysis of carotid artery flow in breast cancer patients treated with supraclavicular irradiation 8 or more years previously: No increase in ipsilateral carotid stenosis after radiation noted","author":"Woodward","year":"2008","journal-title":"Cancer"},{"key":"key-10.4103\/2211-4122.282280-32","first-page":"693","volume-title":"The incidence of cerebrovascular accidents in patients with pituitary adenoma","author":"Brada","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.4103\/2211-4122.282280-33","first-page":"282","volume-title":"Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years","author":"Dorresteijn","year":"2002","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/2211-4122.282280-34","first-page":"395","volume-title":"Carotid artery occlusive disease following external cervical irradiation","author":"Levinson","year":"1973","journal-title":"Arch Surg"},{"key":"key-10.4103\/2211-4122.282280-35","first-page":"359","volume-title":"Arteriosclerosis induced by radiation","author":"Hayward","year":"1972","journal-title":"Surg Clin North Am"},{"key":"key-10.4103\/2211-4122.282280-36","first-page":"499","volume-title":"Ultrasonic analysis of plaque characteristics and intimal-medial thickness in radiation-induced atherosclerotic carotid arteries","author":"Cheng","year":"2002","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"key-10.4103\/2211-4122.282280-37","first-page":"988","volume-title":"Contribution to the pathogenesis of radiation-induced injury to large arteries","author":"Zidar","year":"1997","journal-title":"J Laryngol Otol"},{"key":"key-10.4103\/2211-4122.282280-38","first-page":"538","volume-title":"Delayed cerebrovascular consequences of radiation to the neck.A clinicopathologic study of a case","author":"Nardelli","year":"1978","journal-title":"Arch Neurol"},{"key":"key-10.4103\/2211-4122.282280-39","first-page":"395","volume-title":"Serial changes in arterial structure following radiation therapy","author":"Fonkalsrud","year":"1977","journal-title":"Surg Gynecol Obstet"},{"key":"key-10.4103\/2211-4122.282280-40","first-page":"94","volume-title":"Chronic damage to medium and large arteries following irradiation","author":"Louis","year":"1974","journal-title":"J Can Assoc Radiol"},{"key":"key-10.4103\/2211-4122.282280-41","first-page":"13","volume-title":"The pathology of ionizing radiation as defined by morphologic patterns","author":"Fajardo","year":"2005","journal-title":"Acta Oncol"},{"key":"key-10.4103\/2211-4122.282280-42","first-page":"344","volume-title":"Acute cerebrovascular accident after treatment with cis-platinum and methylprednisolone","author":"Goldhirsch","year":"1983","journal-title":"Oncology"},{"key":"key-10.4103\/2211-4122.282280-43","first-page":"435","volume-title":"Acute cerebrovascular accident after cisplatin treatment in a patient taking letrozole","author":"Digklia","year":"2012","journal-title":"Chemotherapy"},{"key":"key-10.4103\/2211-4122.282280-44","first-page":"274","volume-title":"Acute stroke following cisplatin therapy","author":"Gamble","year":"1998","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"key-10.4103\/2211-4122.282280-45","first-page":"63","volume-title":"Ischemic stroke following cisplatin and 5-fluorouracil therapy: A transcranial doppler study","author":"Serrano-Castro","year":"2000","journal-title":"Eur Neurol"},{"key":"key-10.4103\/2211-4122.282280-46","first-page":"76","volume-title":"Cisplatin-related cerebral infarction in testicular germ cell cancer: Short report of three cases andPin testicular germ cell cancer: Short report of three cases and pathomechanism","author":"Lange","year":"2017","journal-title":"Clin Neurol Neurosurg"},{"key":"key-10.4103\/2211-4122.282280-47","first-page":"31","volume-title":"Impact of platinum-based chemotherapy on the progression of atherosclerosis","author":"Sekijima","year":"2011","journal-title":"Climacteric"},{"key":"key-10.4103\/2211-4122.282280-48","first-page":"899","volume-title":"Brain infarction following 5-fluorouracil and cisplatin therapy","author":"El","year":"1998","journal-title":"Neurology"},{"key":"key-10.4103\/2211-4122.282280-49","first-page":"387","volume-title":"5-fluorouracil-induced leukoencephalopathy with acute stroke-like presentation fulfilling criteria for recombinant tissue plasminogen activator therapy","author":"Kinno","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"key-10.4103\/2211-4122.282280-50","first-page":"215","volume-title":"Reversible leukoencephalopathy with stroke-like presentation in a patient with 5-dihydropyrimidine dehydrogenase deficiency treated with continuous 5-fluorouracil infusion","author":"Li","year":"2012","journal-title":"Clin Colorectal Cancer"},{"key":"key-10.4103\/2211-4122.282280-51","first-page":"1389","volume-title":"Chemotherapy induced stroke mimic: 5-fluorouracil encephalopathy fulfilling criteria for tissue plasminogen activator therapy","author":"Nguyen","year":"2017","journal-title":"Am J Emerg Med"},{"key":"key-10.4103\/2211-4122.282280-52","first-page":"281","volume-title":"Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy","author":"Fraum","year":"2011","journal-title":"J Neurooncol"},{"key":"key-10.4103\/2211-4122.282280-53","first-page":"1561","volume-title":"Bevacizumab and central nervous system (CNS) hemorrhage","author":"Letarte","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"key-10.4103\/2211-4122.282280-54","first-page":"1","volume-title":"An evidence-based review of the incidence of CNS bleeding with anti-VEGF therapy in non-small cell lung cancer patients with brain metastases","author":"Sandler","year":"2012","journal-title":"Lung Cancer"},{"key":"key-10.4103\/2211-4122.282280-55","first-page":"1232","volume-title":"Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab","author":"Scappaticci","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/2211-4122.282280-56","first-page":"252","volume-title":"Afatal brain stroke in patient with advanced breast cancer treated with bevacizumab: A Case report","author":"Domenico","year":"2010","journal-title":"World J Oncol"},{"key":"key-10.4103\/2211-4122.282280-57","first-page":"287","volume-title":"Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis of randomized controlled trials","author":"Ranpura","year":"2010","journal-title":"Acta Oncol"},{"key":"key-10.4103\/2211-4122.282280-58","first-page":"13","volume-title":"Analysis of prothrombotic mechanisms and endothelial perturbation during treatment with angiogenesis inhibitors","author":"Kuenen","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"key-10.4103\/2211-4122.282280-59","first-page":"11","volume-title":"Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond","author":"Di","year":"2017","journal-title":"Int J Cardiol"},{"key":"key-10.4103\/2211-4122.282280-60","first-page":"1365","volume-title":"Chronic vascular toxicity of doxorubicin in an organ-cultured artery","author":"Murata","year":"2001","journal-title":"Br J Pharmacol"},{"key":"key-10.4103\/2211-4122.282280-61","first-page":"166","volume-title":", Hamilton CA, Lane KS, Ntim WO, Lawrence J, et al. Aortic stiffness increases upon receipt of anthracycline chemotherapy","author":"Chaosuwannakit","year":"2010","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/2211-4122.282280-62","first-page":"877","volume-title":", Lawrence J, Avis N, Ellis LR, et al. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease","author":"Drafts","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"key-10.4103\/2211-4122.282280-63","first-page":"140","volume-title":"Early and late changes in markers of aortic stiffness with breast cancer therapy","author":"Grover","year":"2015","journal-title":"Intern Med J"},{"key":"key-10.4103\/2211-4122.282280-64","first-page":"532","volume-title":"Signs of early sub-clinical atherosclerosis in childhood cancer survivors","author":"Dengel","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"key-10.4103\/2211-4122.282280-65","first-page":"1154","volume-title":"Thalidomide and multiple myeloma serum synergistically induce a hemostatic imbalance in endothelial cells in vitro","author":"Gao","year":"2015","journal-title":"Thromb Res"},{"key":"key-10.4103\/2211-4122.282280-66","first-page":"1272","volume-title":"Vascular toxicities of cancer therapies: The old and the new \u2013 An evolving avenue","author":"Herrmann","year":"2016","journal-title":"Circulation"},{"key":"key-10.4103\/2211-4122.282280-67","first-page":"1013","volume-title":"Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: A report from the European Association of cardiovascular imaging and the American Society of Echocardiography","author":"Lancellotti","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"key":"key-10.4103\/2211-4122.282280-68","first-page":"94","volume-title":"Clinical features of radiation-induced carotid atherosclerosis","author":"Gujral","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"key-10.4103\/2211-4122.282280-69","first-page":"36","volume-title":"Carotid stenting for severe radiation-induced extracranial carotid artery occlusive disease","author":"Al-Mubarak","year":"2000","journal-title":"J Endovasc Ther"},{"key":"key-10.4103\/2211-4122.282280-70","first-page":"53","volume-title":"Carotid stenting for radiation-induced extracranial carotid artery occlusive disease: Efficacy and midterm outcomes","author":"Ting","year":"2004","journal-title":"J Endovasc Ther"},{"key":"key-10.4103\/2211-4122.282280-71","first-page":"13","volume-title":"Surgery for carotid artery stenosis following neck irradiation","author":"Friedell","year":"2001","journal-title":"Ann Vasc Surg"},{"key":"key-10.4103\/2211-4122.282280-72","first-page":"110","volume-title":"Radiation arteritis: A contraindication to carotid stenting?","author":"Protack","year":"2007","journal-title":"J Vasc Surg"},{"key":"key-10.4103\/2211-4122.282280-73","first-page":"762","volume-title":"Carotid angioplasty and stenting in anatomically high-risk patients: Safe and durable except for radiation-induced stenosis","author":"Shin","year":"2009","journal-title":"J Vasc Surg"},{"key":"key-10.4103\/2211-4122.282280-74","first-page":"272","volume-title":"Prosthetic carotid bypass grafts for atherosclerotic lesions: A prospective study of 198 consecutive cases","author":"Ricco","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"key-10.4103\/2211-4122.282280-75","first-page":"158","volume-title":"Effects of cancer therapy targeting vascular endothelial growth factor receptor on central blood pressure and cardiovascular system","author":"Moreo","year":"2016","journal-title":"Am J Hypertens"},{"key":"key-10.4103\/2211-4122.282280-76","first-page":"368","volume-title":"Clinical presentation and ischemic zone on MRI in cancer patients with acute ischemic stroke","author":"Seok","year":"2012","journal-title":"Eur Neurol"}],"container-title":["Journal of Cardiovascular Echography"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:47:46Z","timestamp":1786733266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcecho.jcecho_4_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"alternative-id":["282280"],"URL":"https:\/\/doi.org\/10.4103\/jcecho.jcecho_4_19","relation":{},"ISSN":["2211-4122"],"issn-type":[{"value":"2211-4122","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}